Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Alvotech (ALVO)

$4.92 +0.82% NASDAQ: ALVO · 15-min delayed
  • Public · NASDAQ: ALVO
  • 1,460 employees
$1.0BMarket cap
1,460Employees
ALVONASDAQ
2022IPO

About Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Market cap
$1.0B
NASDAQ: ALVO
$4.92 +0.82%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$3.00 $8.98

52-week range

Market cap
$1.0B
Shares outstanding
210.4M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
Jun 16, 2022

Alvotech (ALVO) Stock Price

  • Trading 45% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Alvotech.

Write a review
Newsroom

News about Alvotech

News & sentiment via Polygon.io

FAQ

Alvotech: frequently asked questions

Is Alvotech an American company?

No — Alvotech is not an American company. Alvotech is incorporated in Luxembourg. It maintains US operations and its shares trade on NASDAQ — which is why it is often mistaken for a US company.

Where is Alvotech incorporated?

Alvotech is legally incorporated in Luxembourg, according to its GLEIF legal-entity record.

Is Alvotech traded on a US stock exchange?

Yes — Alvotech trades under the ticker ALVO on the NASDAQ. A US stock listing does not by itself make a company American — incorporation and ownership are what this page reports.

Is Alvotech publicly traded?

Yes — Alvotech is a publicly traded company. Its stock trades under the ticker symbol ALVO on the NASDAQ.

What does Alvotech do?

Alvotech is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →